Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Nabi reports preliminary data from Nabi-Altastaph trial in neonates

May 3, 1999

Iomai demonstrates feasibility and safety of transcutaneous immunization

April 30, 1999

PDL issued U.S. patent covering its SMART anti-CD3 antibody

April 30, 1999

Safety and immunogenicity of TA-GW demonstrated in phase IIa study

April 28, 1999

Canadian launch for world's first Lyme disease vaccine

April 28, 1999

Donor bone marrow: an alternative to immunosuppressive drugs in transplantation?

April 26, 1999

New PRIMATIZED anti-CD80 antibodies engineered at Idec

April 26, 1999

Improved antigen response to conjugate vaccine in mature vs. neonatal mice

April 26, 1999

IDEC-131, an inhibitor of B-cell activation for the treatment of autoimmune disorders

April 23, 1999

GPC and MorphoSys collaborate on human therapeutic antibody program

April 23, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...